Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 7, 2012, Pages 850-858

  Tükel, Raşit ^a   Gürvit, Hakan ^a   Özata, Berna ^a   Öztürk, Nalan ^a   Ertekin, Banu A ^a   Ertekin, Erhan ^a   Baran, Bengi ^a   Kalem, Şükriye A ^a   Büyükgök, Deniz ^a   Direskeneli, Güher S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

BDNF; Executive functions; Genetic polymorphism; Obsessive compulsive disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ALLELE; ARTICLE; CODON; COGNITION; DSM-IV; EXECUTIVE FUNCTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPEECH; TASK PERFORMANCE;

ADOLESCENT; ADULT; ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHIONINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; VALINE;

EID: 84866330012     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32092     Document Type: Article

References (53)

1. Abbruzzese M, Ferri S, Scarone S. 1995. Wisconsin Card Sorting Test performance in obsessive-compulsive disorder: No evidence for involvement of dorsolateral prefrontal cortex. Psychiatry Res 58:37-43.
2. Abbruzzese M, Ferri S, Scarone S. 1997. The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: A double dissociation experimental finding. Neuropsychologia 35:907-912.
3. Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, Baca-García E, Labad J, Fernández-Piqueras J, Real E, Vaquero C, Pérez M, Dolengevich H, González JR, Bayés M, de Cid R, Vallejo J, Estivill X. 2008. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder. Biol Psychiatry 63:619-628.
4. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Press.
5. Anderson KE, Savage CR. 2004. Cognitive and neurobiological findings in obsessive-compulsive disorder. Psychiatr Clin North Am 27:37-47.
6. Barr LC, Goodman WK, Price LH. 1993. The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol 8(Suppl. 2):79-82.
7. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ. 2006. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-868.
8. Boone KB, Ananth J, Philpott L. 1991. Neuropsychological characteristics of nondepressed adults with obsessive-compulsive disorder. Neuropsychiatry Neuropsychol Behav Neurol 4:96-109.
9. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK. 2006. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59:812-815.
10. Cowansage KK, LeDoux JE, Monfils MH. 2010. Brain-derived neurotrophic factor: A dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 3:12-29.
11. Culbertson WC, Zillmer EA. 2005. Tower of London, Drexel University, 2nd edition. Technical manual. Toronto: Multi-Health Systems.
12. da Rocha FF, Malloy-Diniz L, Lage NV, Corrêa H. 2010. Positive association between MET allele (BDNF Val66Met polymorphism) and obsessive-compulsive disorder. Rev Bras Psiquiatr 32:323-324.
13. da Rocha FF, Malloy-Diniz L, Lage NV, Corrêa H. 2011. The relationship between the Met allele of the BDNF Val66Met polymorphism and impairments in decision making under ambiguity in patients with obsessive-compulsive disorder. Genes Brain Behav 10:523-529.
14. Deckersbach T, Otto MW, Savage CR, Baer L, Jenike MA. 2000. The relationship between semantic organization and memory in obsessive-compulsive disorder. Psychother Psychosom 69:101-107.
15. Delis DC, Kramer JH, Kaplan E, Ober BA. 1987. California Verbal Learning Test, Research edition. New York: The Psychological Corporation.
16. Deltheil T, Guiard BP, Guilloux JP, Nicolas L, Deloménie C, Repérant C, Le Maitre E, Leroux-Nicollet I, Benmansour S, Coudoré F, David DJ, Gardier AM. 2008. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: Studies in adult mice hippocampus. Pharmacol Biochem Behav 90:174-183.
17. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269.
18. Eker Ç, Kitis O, Ozan E, Okur H, Eker OD, Ersoy MA, Akdeniz F, Vahip S, Akarsu N, Gönül AS. 2005. BDNF gene Val66met polymorphism associated grey matter changes in human brain. Klin Psikofarmakol Bül 15:104-111.
19. First MB, Spitzer RL, Gibbon M, Williams JBW. 1997. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington, DC: American Psychiatric Press.
20. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. 1989a. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011.
21. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. 1989b. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 46:1012-1016.
22. Gross-Isseroff R, Sasson Y, Voet H, Hendler T, Luca-Haimovici K, Kandel-Sussman H, Zohar J. 1996. Alternation learning in obsessive-compulsive disorder. Biol Psychiatry 39:733-738.
23. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. 2003. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 73:370-376.
24. Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
25. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR. 2003. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23:6690-6694.
26. Heaton RK. 1981. Wisconsin Card Sorting Test manual. Florida: Psychological Assessment Resources.
27. Hemmings SM, Kinnear CJ, Van der Merwe L, Lochner C, Corfield VA, Moolman-Smook JC, Stein DJ. 2008. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD). World J Biol Psychiatry 9:126-134.
28. Hymas N, Lees A, Bolton D, Epps K, Head D. 1991. The neurology of obsessional slowness. Brain 114:2203-2233.
29. Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, Hemmings SM, Carey PD, Stein DJ, Sondervan D, Boer JA, van Balkom AJ, Polman A, Heutink P. 2009. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD). Am J Med Genet Part B 150B:1050-1062.
30. Kuelz AK, Hohagen F, Voderholzer U. 2004. Neuropsychological performance in obsessive-compulsive disorder: A critical review. Biol Psychol 65:185-236.
31. Lu B. 2003. BDNF and activity-dependent synaptic modulation. Learn Mem 10:86-98.
32. Lucey JV, Burness CE, Costa DC, Gacinovic S, Pilowsky LS, Ell PJ, Marks IM, Kerwin RW. 1997. Wisconsin Card Sorting Task (WCST) errors and cerebral blood flow in obsessive-compulsive disorder (OCD). Br J Med Psychol 70:403-411.
33. Mamounas LA, Blue ME, Siuciak JA, Altar CA. 1995. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 15:7929-7939.
34. Moritz S, Birkner C, Kloss M, Jacobsen D, Fricke S, Böthern A, Hand I. 2001. Impact of comorbid depressive symptoms on neuropsychological performance in obsessive-compulsive disorder. J Abnorm Psychol 110:653-657.
35. Moritz S, Birkner C, Kloss M, Jahn H, Hand I, Haasen C, Krausz M. 2002. Executive functioning in obsessive-compulsive disorder, unipolar depression, and schizophrenia. Arch Clin Neuropsychol 17:477-483.
36. Mössner R, Walitza S, Lesch KP, Geller F, Barth N, Remschmidt H, Hahn F, Herpertz-Dahlmann B, Fleischhaker C, Schulz E, Warnke A, Hinney A, Wewetzer C. 2005. Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive-compulsive disorder. Int J Neuropsychopharmacol 8:133-136.
37. Nakao T, Nakagawa A, Nakatani E, Nabeyama M, Sanematsu H, Yoshiura T, Togao O, Tomita M, Masuda Y, Yoshioka K, Kuroki T, Kanba S. 2009. Working memory dysfunction in obsessive-compulsive disorder: A neuropsychological and functional MRI study. J Psychiatr Res 43:784-791.
38. Okasha A, Rafaat M, Mahallawy N, El Nahas G, El Dawla AS, Sayed M, El Kholi S. 2000. Cognitive dysfunction in obsessive-compulsive disorder. Acta Psychiatr Scand 101:281-285.
39. Penadés R, Catalán R, Andrés S, Salamero M, Gastó C. 2005. Executive function and nonverbal memory in obsessive-compulsive disorder. Psychiatry Res 133:81-90.
40. Pivac N, Kim B, Nedić G, Joo YH, Kozarić-Kovacić D, Hong JP, Muck-Seler D. 2009. Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants. Croat Med J 50:43-48.
41. Rybakowski JK, Borkowska A, Czerski PM, Skibińska M, Hauser J. 2003. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5:468-472.
42. Rybakowski JK, Borkowska A, Skibinska M, Hauser J. 2006. Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol Psychiatry 11:122-124.
43. Savage CR, Deckersbach T, Wilhelm S, Rauch SL, Baer L, Reid T, Jenike MA. 2000. Strategic processing and episodic memory impairment in obsessive compulsive disorder. Neuropsychology 14:141-151.
44. Savitz J, Solms M, Ramesar R. 2006. The molecular genetics of cognition: Dopamine, COMT and BDNF. Genes Brain Behav 5:311-328.
45. Shimizu E, Hashimoto K, Iyo M. 2004. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits. Am J Med Genet Part B 126B:122-123.
46. Siuciak JA, Boylan C, Fritsche M, Altar CA, Lindsay RM. 1996. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 710:11-20.
47. Spreen O, Strauss E. 1991. A compendium of neuropsychological tests: Administration, norms and commentary. New York: Oxford University Press.
48. Tramontina JF, Yates D, Magalhães PV, Trentini C, Sant'anna MK, Fries GR, Bock H, Saraiva-Pereira ML, Kapczinski F. 2009. Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder. Rev Bras Psiquiatr 31:136-140.
49. Tukel R, Gürvit H, Ertekin BA, Oflaz S, Ertekin E, Baran B, Kalem SA, Kandemir PE, Ozdemiroǧlu FA, Atalay F. 2012. Neuropsychological function in obsessive-compulsive disorder. Compr Psychiatry 53:167-175.
50. Wendland JR, Kruse MR, Cromer KR, Murphy DL. 2007. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology 32:2543-2551.
51. Westenberg HGM, Fineberg NA, Denys D. 2007. Neurobiology of obsessive-compulsive disorder: Serotonin and beyond. CNS Spectr 12(Suppl. 3):14-27.
52. Zai G, Arnold P, Strauss J, King N, Burroughs E, Richter MA, Kennedy JL. 2005. No association between brain-derived neurotrophic factor gene and obsessive-compulsive disorder. Psychiatr Genet 15:235.
53. Zielinski CM, Taylor MA, Juzwin KR. 1991. Neuropsychological deficits in obsessive-compulsive disorder. Neuropsychiatry Neuropsychol Behav Neurol 4:110-116.